Raymond James Financial Services Advisors, Inc. Cti Biopharma Corp Transaction History

Raymond James Financial Services Advisors, Inc.

  • $73.5 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 25, 2022
BUY
$5.36 - $7.43 $94,180 - $130,552
17,571 New
17,571 $102,000
Q2 2022

Aug 12, 2022
SELL
$3.55 - $6.27 $55,277 - $97,630
-15,571 Closed
0 $0
Q1 2022

May 11, 2022
BUY
$1.9 - $5.23 $29,584 - $81,436
15,571 New
15,571 $73,000
Q4 2021

Feb 08, 2022
SELL
$1.44 - $2.86 $104,934 - $208,411
-72,871 Closed
0 $0
Q3 2021

Nov 02, 2021
BUY
$2.25 - $3.18 $163,959 - $231,729
72,871 New
72,871 $215,000

About CTI BIOPHARMA CORP

CTIC Quotes by TradingView
  • Ticker CTIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 114,385,000
  • Market Cap $1.04B
  • Description
  • CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...
More about CTIC
Track This Portfolio

Track Raymond James Financial Services Advisors, Inc. Portfolio

Follow Raymond James Financial Services Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email